Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
65,128,864
-
Shares change
-
+4,264,277
-
Total reported value, excl. options
-
$176,503,793
-
Value change
-
+$10,344,308
-
Put/Call ratio
-
153%
-
Number of buys
-
71
-
Number of sells
-
-61
-
Price
-
$2.71
Significant Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q4 2021
184 filings reported holding CLVSQ - CLOVIS ONCOLOGY INC - COM as of Q4 2021.
CLOVIS ONCOLOGY INC - COM (CLVSQ) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65,128,864 shares
.
Largest 10 shareholders include STATE STREET CORP (16,114,542 shares), VANGUARD GROUP INC (10,115,101 shares), BlackRock Inc. (9,732,570 shares), Palo Alto Investors LP (3,997,826 shares), GEODE CAPITAL MANAGEMENT, LLC (2,212,612 shares), BANK OF AMERICA CORP /DE/ (1,522,792 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,355,881 shares), Rafferty Asset Management, LLC (1,333,278 shares), NORTHERN TRUST CORP (1,166,363 shares), and Ikarian Capital, LLC (1,112,669 shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.